Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects

B. Ya. Alekseev; I. M. Shevchuk

Cancer Urology
Onkourologiâ

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

User

eng | рус

Cancer Urology

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Alekseev B.Ya., Shevchuk I.M. Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects. Cancer Urology. 2020;16(3):38-52. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-3-38-52

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Boris Ya. Alekseev

About the Authors

B. Ya. Alekseev
National Medical Research Radiological Center, Ministry of Health of Russia; Department of Oncology, Medical Institute of Continuing Education, Moscow State University of Food Production
Russian Federation

3 2nd Botkinskiy Proezd, Moscow 125284; 11 Volokolamskoe Shosse, Moscow 125080.

I. M. Shevchuk
National Medical Research Radiological Center, Ministry of Health of Russia; Department of Oncology, Medical Institute of Continuing Education, Moscow State University of Food Production
Russian Federation

3 2nd Botkinskiy Proezd, Moscow 125284; 11 Volokolamskoe Shosse, Moscow 125080.

Notifications

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Cancer Urology

For citations:

Cookies policy